Hypoglycemia induced by long-acting somatostatin analogues in a patient with nonfunctional neuroendocrine tumor

ÜNEK İ. T., ÇELTİK A., Yener S., YAVUZŞEN T., Alacacioglu A., Cokmert S., ...More

JOURNAL OF BUON, vol.14, no.1, pp.135-138, 2009 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 14 Issue: 1
  • Publication Date: 2009
  • Journal Name: JOURNAL OF BUON
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.135-138
  • Keywords: hypoglycemia, neuroendocrine tumor, somatostatin analogues, OCTREOTIDE, DIAGNOSIS
  • Dokuz Eylül University Affiliated: Yes


Somatostatin and its long-acting analogues are effective in symptom control in patients with functional neuroendocrine tumors; they are also able to control tumor growth. Somatostatin analogues are safe and generally well tolerated. In some cases they may cause serious complications.